Audio is streamed from the publisher.
Show notes
A new mRNA vaccine for melanoma is [https://www.nbcnews.com/health/health-news/merck-moderna-say-melanoma-vaccine-promise-prevent-recurrence-cancer-rcna593316"]( making headlines. Moderna and Merck recently announced results from their clinical trial suggesting that this new vaccine, in combination with the cancer drug Keytruda, reduced recurrence rates in patients. The companies have not yet released full data from the trial. So, [https://www.sciencefriday.com/segments/mrna-melanoma-vaccine/?utm\_source=wnyc&utm\_medium=podcast&utm\_campaign=scifri"]( how does the vaccine work? And does this mark the beginning of a new era of cancer treatments using mRNA vaccine technology? Ira talks with physician Michael Postow, whose patients were part of the drug trial at Memorial Sloan Kettering Cancer Center. Guest: Dr. Michael Postow is chief of the melanoma service at Memorial Sloan Kettering Cancer Center. _Transcript will be available after the show airs on_ [https://www.sciencefriday.com/segments/mrna-melanoma-vaccine/?utm\_source=wnyc&utm\_medium=podcast&utm\_campaign=scifri"]( _sciencefriday.com._ [https://pod.link/73329284"]( _Subscribe to this podcast._ _Follow our show on_ [https://www.instagram.com/scifri/"]( _Instagram_ _,_ [https://www.tiktok.com/@scifri"]( _TikTok_ _,_ [https://www.facebook.com/scifri"]( _Facebook_ _, and_ [https://bsky.app/profile/scifri.bsky.social"]( _Bluesky_ _@scifri and_ [https://www.sciencefriday.com/newsletters/?utm\_source=wnyc&utm\_medium=podcast&utm\_campaign=scifri"]( _sign up for our newsletters_ _. Got a science question that’s keeping you up at night? Call us:_ _877-472-4374_ Hosted by Simplecast, an AdsWizz company. See [pcm.adswizz.com]( https://pcm.adswizz.com">pcm.adswizz.com for information about our collection and use of personal data for advertising.